Clinical Trials Directory

Trials / Sponsors / Imugene Limited

Imugene Limited

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
TerminatedA Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Soli
Solid Tumor, Adult
Phase 12023-10-02
TerminatedA Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HE
Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma
Phase 22022-08-17
TerminatedA Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adu
Solid Tumor, Solid Carcinoma, Solid Tumor, Adult
Phase 12022-05-17
TerminatedA Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV
Phase 12020-11-30
RecruitingLong-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
—2020-08-25
RecruitingDose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refra
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia
Phase 12019-03-11
CompletedA Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Adv
Gastrointestinal Neoplasms, Adenocarcinoma
Phase 1 / Phase 22017-08-30